Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · IEX Real-Time Price · USD
5.80
+0.11 (1.93%)
At close: Feb 23, 2024, 4:00 PM
5.72
-0.08 (-1.38%)
After-hours: Feb 23, 2024, 7:48 PM EST

Amneal Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017201620152014
Revenue
2,2122,0941,9931,6261,6631,0341,018866.28785.62
Revenue Growth (YoY)
5.67%5.08%22.51%-2.20%60.88%1.52%17.54%10.27%-
Cost of Revenue
1,4281,3251,3641,273946.59507.48420.77364.6337.2
Gross Profit
784.71768.97628.39353716.4526.18597.46501.68448.42
Selling, General & Admin
399.7365.5326.73289.6227.85109.05118.7697.1884.62
Research & Development
195.69201.85179.93188.05194.19171.42179.02136.87106.74
Other Operating Expenses
283.5248.7130.58124.03314.040.6114.831.4838.5
Operating Expenses
878.91616.06537.24601.68736.08281.08312.57265.53229.85
Operating Income
-94.2152.9291.16-248.68-19.67245.1284.88236.16218.58
Interest Expense / Income
158.38136.33146168.21143.5771.0655.2845.8430.66
Other Expense / Income
-129.25-5.23-41.54-438.3-140.91172.04224.215.929.47
Pretax Income
-123.3221.82-13.321.41-22.3425.4174.4178.44
Income Tax
6.6611.2-104.36383.33-1.4225.44.951.51
Net Income
-129.9910.6291.06-361.92-20.9200169.45176.93
Net Income Growth
--88.33%------4.23%-
Shares Outstanding (Basic)
151149147132127298298--
Shares Outstanding (Diluted)
151152149132127----
Shares Change
-0.58%1.95%12.72%3.81%-57.36%----
EPS (Basic)
-0.860.070.62-2.74-0.16----
EPS (Diluted)
-0.860.070.61-2.74-0.16----
EPS Growth
--88.52%-------
Free Cash Flow
16.31190.88317.17-45.48192.49139.42-7.7-12.532.87
Free Cash Flow Per Share
0.111.282.15-0.341.510.47-0.03--
Gross Margin
35.47%36.73%31.54%21.70%43.08%50.90%58.68%57.91%57.08%
Operating Margin
-4.26%7.30%4.57%-15.29%-1.18%23.71%27.98%27.26%27.82%
Profit Margin
-5.88%0.51%4.57%-22.25%-1.26%--19.56%22.52%
Free Cash Flow Margin
0.74%9.12%15.92%-2.80%11.57%13.49%-0.76%-1.44%4.18%
Effective Tax Rate
-51.31%-1790.10%-100.00%100.00%2.84%0.85%
EBITDA
275.23391.55368.09396.85258.6411993.69245.68229.45
EBITDA Margin
12.44%18.70%18.47%24.40%15.55%11.51%9.20%28.36%29.21%
Depreciation & Amortization
240.18233.41235.39207.24137.445.9433.0225.4520.34
EBIT
35.05158.15132.7189.62121.2373.0660.68220.24209.11
EBIT Margin
1.58%7.55%6.66%11.66%7.29%7.07%5.96%25.42%26.62%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).